top of page
  • Writer's pictureRuss Newton

Turn down for possible ALS Treatment. What a kick in the Ass. They have something that shows promise

yet it is not possible for me to get in.

Russell Newton,

Thank you for reaching out to Brainstorm Cell Therapeutics. We understand the serious unmet medical need and the urgency of people living with ALS. As you mentioned, BrainStorm completed a randomized, double-blind, placebo-controlled multi-dose Phase 3 trial at multiple sites in the United States.

Read about top-line results: BrainStorm Announces Topline Results from NurOwn® Phase 3 ALS Study - Nov 17, 2020 ( We continue to analyze the data and will share additional data in the weeks and months to come at scientific symposiums. ​We are also assessing potential regulatory pathways that would make NurOwn available to patients.

Read about recent updates: BrainStorm Announces Full Year 2020 Financial Results and Provides a Corporate Update - Feb 4, 2021 (

The investigational therapy NurOwn is not available through any pre-approval pathway anywhere in the world at this time including Israel. The expanded access program is for Phase 3 participants who have completed the randomized controlled trial only.

You may also explore the press release section of our website for the most current information. We recommend that you sign up for our news alerts to receive Brainstorm updates.

Thank you for your support of BrainStorm.


Mary Kay Turner

Vice President

Patient Advocacy and Government Affairs

Brainstorm Cell Therapeutics Ltd.

1325 Avenue of the Americas

New York, NY 10019

133 views2 comments

Recent Posts

See All
bottom of page